• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个甲基化-磷酸化开关决定了 Plk1 激酶在 DNA 损伤修复中的活性和功能。

A methylation-phosphorylation switch determines Plk1 kinase activity and function in DNA damage repair.

机构信息

Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China.

Medical Research Institute, School of Medicine, Wuhan University, Wuhan 430071, China.

出版信息

Sci Adv. 2019 Mar 6;5(3):eaau7566. doi: 10.1126/sciadv.aau7566. eCollection 2019 Mar.

DOI:10.1126/sciadv.aau7566
PMID:30854428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6402851/
Abstract

Polo-like kinase 1 (Plk1) is a crucial regulator of cell cycle progression; but the mechanism of regulation of Plk1 activity is not well understood. We present evidence that Plk1 activity is controlled by a balanced methylation and phosphorylation switch. The methyltransferase G9a monomethylates Plk1 at Lys209, which antagonizes phosphorylation of T210 to inhibit Plk1 activity. We found that the methyl-deficient Plk1 mutant K209A affects DNA replication, whereas the methyl-mimetic Plk1 mutant K209M prolongs metaphase-to-anaphase duration through the inability of sister chromatids separation. We detected accumulation of Plk1 K209me1 when cells were challenged with DNA damage stresses. Ablation of K209me1 delays the timely removal of RPA2 and RAD51 from DNA damage sites, indicating the critical role of K209me1 in guiding the machinery of DNA damage repair. Thus, our study highlights the importance of a methylation-phosphorylation switch of Plk1 in determining its kinase activity and functioning in DNA damage repair.

摘要

丝氨酸/苏氨酸激酶 Polo-like 激酶 1(Plk1)是细胞周期进程的关键调节因子;但 Plk1 活性的调节机制尚不清楚。我们提出证据表明,Plk1 活性受甲基化和磷酸化平衡开关控制。甲基转移酶 G9a 将 Plk1 赖氨酸 209 单甲基化,拮抗 T210 的磷酸化,从而抑制 Plk1 活性。我们发现,缺乏甲基的 Plk1 突变体 K209A 会影响 DNA 复制,而甲基模拟的 Plk1 突变体 K209M 通过姐妹染色单体分离的能力丧失延长了中期到后期的持续时间。当细胞受到 DNA 损伤应激时,我们检测到 Plk1 K209me1 的积累。K209me1 的缺失会延迟 RPA2 和 RAD51 从 DNA 损伤部位的及时去除,表明 K209me1 在指导 DNA 损伤修复机制中的关键作用。因此,我们的研究强调了 Plk1 的甲基化-磷酸化开关在决定其激酶活性和在 DNA 损伤修复中的功能的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/e238aab8b14c/aau7566-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/a06461f70878/aau7566-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/5702801f38ca/aau7566-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/5a9b22d746f3/aau7566-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/8d2249d56213/aau7566-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/92034934538a/aau7566-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/e238aab8b14c/aau7566-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/a06461f70878/aau7566-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/5702801f38ca/aau7566-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/5a9b22d746f3/aau7566-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/8d2249d56213/aau7566-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/92034934538a/aau7566-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785e/6402851/e238aab8b14c/aau7566-F6.jpg

相似文献

1
A methylation-phosphorylation switch determines Plk1 kinase activity and function in DNA damage repair.一个甲基化-磷酸化开关决定了 Plk1 激酶在 DNA 损伤修复中的活性和功能。
Sci Adv. 2019 Mar 6;5(3):eaau7566. doi: 10.1126/sciadv.aau7566. eCollection 2019 Mar.
2
The Functional Significance of Posttranslational Modifications on Polo-Like Kinase 1 Revealed by Chemical Genetic Complementation.化学遗传学互补揭示的翻译后修饰对Polo样激酶1的功能意义
PLoS One. 2016 Feb 26;11(2):e0150225. doi: 10.1371/journal.pone.0150225. eCollection 2016.
3
Polo-like kinase 1 mediates BRCA1 phosphorylation and recruitment at DNA double-strand breaks.Polo样激酶1介导BRCA1在DNA双链断裂处的磷酸化和募集。
Oncotarget. 2016 Jan 19;7(3):2269-83. doi: 10.18632/oncotarget.6825.
4
Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.依赖Plk1的磷酸化作用在细胞周期进程中调节DNA拓扑异构酶IIα的功能。
J Biol Chem. 2008 Mar 7;283(10):6209-21. doi: 10.1074/jbc.M709007200. Epub 2008 Jan 2.
5
Polo-like kinase 1 (PLK1)-dependent phosphorylation of methylenetetrahydrofolate reductase (MTHFR) regulates replication via histone methylation.丝氨酸苏氨酸激酶 1(PLK1)依赖性亚甲基四氢叶酸还原酶(MTHFR)的磷酸化调节通过组蛋白甲基化进行的复制。
Cell Cycle. 2017 Oct 18;16(20):1933-1942. doi: 10.1080/15384101.2017.1363942. Epub 2017 Aug 18.
6
DNA-PKcs associates with PLK1 and is involved in proper chromosome segregation and cytokinesis.DNA依赖蛋白激酶催化亚基(DNA-PKcs)与 polo样激酶1(PLK1)相关联,并参与正确的染色体分离和胞质分裂。
J Cell Biochem. 2014 Jun;115(6):1077-88. doi: 10.1002/jcb.24703.
7
BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress.BRCA1 下调 Polo 样激酶 1 的激酶活性以响应复制应激。
Cell Cycle. 2013 Jul 15;12(14):2255-65. doi: 10.4161/cc.25349.
8
WAC Promotes Polo-like Kinase 1 Activation for Timely Mitotic Entry.WAC 促进 Polo 样激酶 1 的激活以实现及时的有丝分裂进入。
Cell Rep. 2018 Jul 17;24(3):546-556. doi: 10.1016/j.celrep.2018.06.087.
9
Identification of potential Plk1 targets in a cell-cycle specific proteome through structural dynamics of kinase and Polo box-mediated interactions.通过激酶结构动力学和 Polo 盒介导的相互作用研究细胞周期特异性蛋白质组中的潜在 Plk1 靶标。
PLoS One. 2013 Aug 15;8(8):e70843. doi: 10.1371/journal.pone.0070843. eCollection 2013.
10
The Plk1 Polo box domain mediates a cell cycle and DNA damage regulated interaction with Chk2.Polo样激酶1(Plk1)的Polo盒结构域介导了与Chk2的细胞周期和DNA损伤调节相互作用。
Cell Cycle. 2005 Apr;4(4):609-17. Epub 2005 Apr 9.

引用本文的文献

1
DDX1 methylation mediated MATR3 splicing regulates intervertebral disc degeneration by initiating chromatin reprogramming.DDX1甲基化介导的MATR3剪接通过启动染色质重编程来调节椎间盘退变。
Nat Commun. 2025 Jul 4;16(1):6153. doi: 10.1038/s41467-025-61486-7.
2
PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid Leukemia.PLK1抑制在范可尼贫血通路缺陷的急性髓系白血病中诱导合成致死
Cancer Res Commun. 2025 Apr 1;5(4):648-667. doi: 10.1158/2767-9764.CRC-24-0260.
3
EHMT2-mediated R-loop formation promotes the malignant progression of prostate cancer via activating Aurora B.

本文引用的文献

1
DNA Replication Determines Timing of Mitosis by Restricting CDK1 and PLK1 Activation.DNA 复制通过限制 CDK1 和 PLK1 的激活来决定有丝分裂的时间。
Mol Cell. 2018 Jul 5;71(1):117-128.e3. doi: 10.1016/j.molcel.2018.05.026. Epub 2018 Jun 28.
2
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration.组蛋白甲基转移酶 G9a/GLP 通过甲基化缺氧诱导因子(HIF)-1α 抑制 HIF-1 转录活性和细胞迁移。
Nucleic Acids Res. 2018 Jul 27;46(13):6576-6591. doi: 10.1093/nar/gky449.
3
AUNIP/C1orf135 directs DNA double-strand breaks towards the homologous recombination repair pathway.
EHMT2介导的R环形成通过激活Aurora B促进前列腺癌的恶性进展。
Clin Transl Med. 2025 Jan;15(1):e70164. doi: 10.1002/ctm2.70164.
4
Methylation of KSHV vCyclin by PRMT5 contributes to cell cycle progression and cell proliferation.PRMT5 介导的 KSHV vCyclin 甲基化促进细胞周期进程和细胞增殖。
PLoS Pathog. 2024 Sep 10;20(9):e1012535. doi: 10.1371/journal.ppat.1012535. eCollection 2024 Sep.
5
Post-translational modifications: The potential ways for killing cancer stem cells.翻译后修饰:杀死癌症干细胞的潜在途径。
Heliyon. 2024 Jul 4;10(14):e34015. doi: 10.1016/j.heliyon.2024.e34015. eCollection 2024 Jul 30.
6
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas.奥凡妥昔单抗治疗克服高级别卵巢癌中奥拉帕利的耐药性。
Cell Death Dis. 2024 Jul 22;15(7):521. doi: 10.1038/s41419-024-06894-1.
7
GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms.GLP和G9a组蛋白甲基转移酶作为淋巴样肿瘤的潜在治疗靶点。
Cancer Cell Int. 2024 Jul 12;24(1):243. doi: 10.1186/s12935-024-03441-y.
8
Targeted PLK1 suppression through RNA interference mediated by high-fidelity Cas13d mitigates osteosarcoma progression via TGF-β/Smad3 signalling.通过高保真 Cas13d 介导的 RNA 干扰靶向 PLK1 抑制通过 TGF-β/Smad3 信号减轻骨肉瘤进展。
J Cell Mol Med. 2024 May;28(10):e18400. doi: 10.1111/jcmm.18400.
9
Exploring Prognostic Gene Factors in Breast Cancer via Machine Learning.通过机器学习探索乳腺癌的预后基因因素。
Biochem Genet. 2024 Dec;62(6):5022-5050. doi: 10.1007/s10528-024-10712-w. Epub 2024 Feb 21.
10
The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma.PLK1/p-PLK1 蛋白在 NK/T 细胞淋巴瘤中的表达及临床意义。
Diagn Pathol. 2023 Nov 30;18(1):129. doi: 10.1186/s13000-023-01413-w.
AUNIP/C1orf135将DNA双链断裂导向同源重组修复途径。
Nat Commun. 2017 Oct 17;8(1):985. doi: 10.1038/s41467-017-01151-w.
4
The role of poly ADP-ribosylation in the first wave of DNA damage response.多聚 ADP 核糖基化在第一波 DNA 损伤反应中的作用。
Nucleic Acids Res. 2017 Aug 21;45(14):8129-8141. doi: 10.1093/nar/gkx565.
5
Methylation of DNA Ligase 1 by G9a/GLP Recruits UHRF1 to Replicating DNA and Regulates DNA Methylation.DNA 连接酶 1 的 G9a/GLP 甲基化将 UHRF1 募集到复制 DNA 并调节 DNA 甲基化。
Mol Cell. 2017 Aug 17;67(4):550-565.e5. doi: 10.1016/j.molcel.2017.07.012. Epub 2017 Aug 10.
6
G9a coordinates with the RPA complex to promote DNA damage repair and cell survival.G9a 与 RPA 复合物协同作用,促进 DNA 损伤修复和细胞存活。
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6054-E6063. doi: 10.1073/pnas.1700694114. Epub 2017 Jul 11.
7
ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration.染色质上的 ATM/Wip1 活性控制 Plk1 的重新激活,以确定 G2 期检查点的持续时间。
EMBO J. 2017 Jul 14;36(14):2161-2176. doi: 10.15252/embj.201696082. Epub 2017 Jun 12.
8
RFWD3-Mediated Ubiquitination Promotes Timely Removal of Both RPA and RAD51 from DNA Damage Sites to Facilitate Homologous Recombination.RFWD3 介导的泛素化促进了 RPA 和 RAD51 从 DNA 损伤部位的及时去除,从而促进同源重组。
Mol Cell. 2017 Jun 1;66(5):622-634.e8. doi: 10.1016/j.molcel.2017.04.022.
9
Plk1 Phosphorylation of Mre11 Antagonizes the DNA Damage Response.Plk1对Mre11的磷酸化作用拮抗DNA损伤反应。
Cancer Res. 2017 Jun 15;77(12):3169-3180. doi: 10.1158/0008-5472.CAN-16-2787. Epub 2017 May 16.
10
Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by Bora.在DNA损伤反应过程中,Polo样激酶1的抑制是通过Bora介导的极光激酶A募集缺失来实现的。
Oncogene. 2017 Mar 30;36(13):1840-1848. doi: 10.1038/onc.2016.347. Epub 2016 Oct 10.